Literature DB >> 21060622

Fringe visibility, irradiance, and accuracy in common path interferometers for visualization of phase disturbances.

C S Anderson.   

Abstract

Common-path interferometers have been used to perform phase visualization for over 40 years. A number of techniques have been proposed, including dark central ground, phase contrast (π/2 and π), and field-absorption interferometers. The merits of the interferometers have been judged ad hoc by either tests with a small number of phase objects or by computer simulation. Three standardized criteria, which consolidate the work of others, are proposed to evaluate common-path interferometers: fringe visibility, fringe irradiance, and fringe accuracy. The interferometers can be described as one generic class of Fourier-plane filters and can be analyzed for all input conditions. Closed-form expressions are obtained for visibility and irradiance under the forced condition that little inaccuracy is tolerated. This analysis finds that the π-phase-contrast interferometer is a good choice if the optical phase disturbance is at least 2π; for smaller disturbances, the Π/2 filter selected by Zernike is near optimum. It is shown mathematically that the resulting fringe visibility is highly object dependent, and good results are not ensured. By allowing the optical beam to be 50% larger than the phase object, the interferometer performs well under all conditions. With this approach and a combination π-phase/field-absorption filter, interference fringe visibility is greater than 0.8 for all phase objects.

Entities:  

Year:  1995        PMID: 21060622     DOI: 10.1364/AO.34.007474

Source DB:  PubMed          Journal:  Appl Opt        ISSN: 1559-128X            Impact factor:   1.980


  1 in total

1.  Reflective interferometric chamber for quantitative phase imaging of biological sample dynamics.

Authors:  Natan T Shaked; Yizheng Zhu; Nima Badie; Nenad Bursac; Adam Wax
Journal:  J Biomed Opt       Date:  2010 May-Jun       Impact factor: 3.170

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.